BHG - Bright Health Group reports Q3 mixed earnings; revises Fy22 guidance
- Bright Health Group press release ( NYSE: BHG ): Q3 GAAP EPS of -$0.50 misses by $0.12 .
- Revenue of $1.63B (+50.9% Y/Y) misses by $190M .
- Lowering Full Year 2022 Enterprise Medical Cost Ratio guidance range to 90% to 92%.
- Positively revising Full Year 2022 Adjusted EBITDA loss guidance range to $550 to $700 million.
For further details see:
Bright Health Group reports Q3 mixed earnings; revises Fy22 guidance